Based in San Antonio, Texas, OncoVista was incorporated in 2004 and will utilize state-of-the-art drug discovery technologies, innovative clinical development and registration strategies as well as emerging nanotechnologies to bring to market new, safe and highly efficient anti-cancer drugs. The combination of OncoVista's extensive in-house pre-clinical and clinical expertise with its global drug development network will lead to rapid and cost-effective regulatory approval and commercialization of novel therapies for the treatment of cancer.
R&D
To view this information, you must subscribe to Partneringtools.
Partnerships
To view this information, you must subscribe to Partneringtools.
Deals
To view this information, you must subscribe to Partneringtools.
Senior management
To view this information, you must subscribe to Partneringtools.
Head office
To view this information, you must subscribe to Partneringtools.
Industry news: Pharmalicensing provides comprehensive industry coverage.